Showing results (281-290 of 364) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|January 12, 2010
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosisYuan-Hung Kuo, Sheng-Nan Lu, Chao-Long Chen, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2016
Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapyCheng-Kun Wu, Kuo-Chin Chang, Chao-Hung Hung, et al.
Clinical and Translational Gastroenterology|June 30, 2017
A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute ExacerbationChao-Hung Hung, Kwong-Ming Kee, Chih-Hung Chen, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2015
Tenofovir versus entecavir in treatment of chronic hepatitis B virus with severe acute exacerbationChao-Hung Hung, Tsung-Hui Hu, Sheng-Nan Lu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 1, 2025
Proton beam therapy versus trans-arterial chemoembolization for BCLC stage B hepatocellular carcinoma-a propensity-matched analysisTzu-Ting Liu, Bing-Shen Huang, Yu-Ming Wang, et al.
Plos One|April 15, 2020
Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatmentShao-Ming Chiu, Ming-Chao Tsai, Chun-Yen Lin, et al.
Scientific Reports|May 1, 2020
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgeryWei-Ru Cho, Chao-Hung Hung, Chien-Hung Chen, et al.
Plos One|March 4, 2021
Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patientsWei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, et al.
Journal of Gastroenterology and Hepatology|July 4, 2018
Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapyHung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, et al.
Helicobacter|April 21, 2012
Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pyloriSeng-Kee Chuah, Ping-I Hsu, Kuo-Chin Chang, et al.
Pageof 37